- The new vaccine is “similar to the existing mRNA vaccine but uses a smaller protein,” Kennedy says in a post on X
- The FDA will monitor and collect data throughout the trial for every adverse outcome: Kennedy
To contact the reporter on this story:
To contact the editors responsible for this story:
Airielle Lowe
© 2025 Bloomberg L.P. All rights reserved. Used with permission.